DUBLIN--(BUSINESS WIRE)--The "Global Wearable Artificial Kidney Market (2022-2027) by Dialysis Type, Disease, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Wearable Artificial Kidney Market is estimated to be USD 137.16 Mn in 2022 and is expected to reach USD 350.06 Mn by 2027, growing at a CAGR of 20.61%.
Market dynamics are forces that impact the prices and behaviors of the Global Wearable Artificial Kidney Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario.
Some of the companies covered in this report are Asahi Kasei Medical Co., Ltd., B. Braun Melsungen Ag, Baxter International Inc., Cardinal Health, Inc., Wearable Artificial Organs, Inc., etc.
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories.
Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Wearable Artificial Kidney Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company.
The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
Market Segmentations
- By Dialysis Type, the market is classified into Hemodialysis and Peritoneal Dialysis.
- By Disease, the market is classified into Acute Renal Disease and End-Stage Renal Disease.
- By End-User, the market is classified into Ambulatory Surgical Centers, Dialysis Centers, and Hospitals.
Market Dynamics
Drivers
- Low Presence of Donors, Leading to Limited Transplantation
- Rising Prevalence of Various Renal Failure Diseases, Chronic Diseases
Restraints
- Stringent Regulatory Policies for Dialysis Products
Opportunities
- Technological Advancement in Artificial Kidney
- Increase Awareness Among Patients for Ambulatory Dialysis
Challenges
- Risk of Complications of Using Artificial Kidney
Company Profiles
- Asahi Kasei Medical Co., Ltd.
- AWAK Technologies Pte. Ltd.
- B. Braun Melsungen Ag
- Baxter International Inc.
- Cardinal Health, Inc.
- Nanodialysis BV
- Nephria Bio, Inc.
- Triomed AB
- Wearable Artificial Organs, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/86x2fd
